SANIA THERAPEUTICS
Sania Therapeutics is a gene therapy company that develops therapies that are specifically targeted to neural circuits.
SANIA THERAPEUTICS
Social Links:
Industry:
Biotechnology Genetics Health Care Therapeutics
Founded:
2021-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.saniarx.com
Total Employee:
1+
Status:
Active
Contact:
+44 753 925 5593
Total Funding:
5.05 M USD
Current Employees Featured
Founder
Official Site Inspections
http://www.saniarx.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147

More informations about "Sania Therapeutics"
About - Sania Therapeutics
Sania Therapeutics was founded in March 2022 with a powerful vision: to build the safest and most effective genetic medicines that can be used to improve the quality of life for as many โฆSee details»
Sania Therapeutics | Novel medicines for neural circuit โฆ
Sania [sah-nee-ah] harnesses our nervous system as an access point to treating a broad range of prevalent and underserved disease areas. Our precision therapies combine targeted delivery with a controllable therapeutic to redefine โฆSee details»
Team - Sania Therapeutics
Aspiring and formidable, our team is at the heart of Sania. We are a highly motivated group of experts and innovators with a broad range of expertise working together to build new โฆSee details»
Sania Therapeutics - Crunchbase Company Profile
Sania Therapeutics is a biotech company developing gene therapies for nervous system disorders. The company was founded in 2022 and is headquartered in โฆSee details»
Sania Therapeutics - LinkedIn
Sania Therapeutics | 2,593 followers on LinkedIn. Precision genetic neuromodulation for neural circuit dysfunction | Built for precision, designed for patients. Sania [sah-nee-ah] is a London ...See details»
Sania Therapeutics - Our spinouts - Portfolio - UCLB
Saniaโs approach harnesses neural circuits as a gateway to disease states. Their research and development is centred around a human-first approach to ultimately build more translatable, โฆSee details»
Sania Therapeutics presents latest from AAV gene therapy
Apr 23, 2024 Sania Therapeutics Andrew Murray +4407354836683 [email protected]: ICR Consilium Mary-Jane Elliott Lucy Featherstone +44 (0)20 3709 5700 โฆSee details»
Contact Us - Sania Therapeutics
Sania Therapeutics logo and icon below (png). For illustrations, contact [email protected]See details»
Sania Therapeutics launches to advance novel medicines for neural ...
May 17, 2023 For more information visit www.saniarx.com. Sania Therapeutics Andrew Murray +4407354836683 [email protected] : Consilium Strategic Communications Mary-Jane Elliott โฆSee details»
Sania Therapeutics - PitchBook
Sania Therapeutics General Information Description. Developer of gene therapies intended to improve the quality of life of people with neurological diseases. The company uses virology, molecular biology, and bioinformatics to build โฆSee details»
Sania Therapeutics - VentureRadar
Sania is a next-gen AAV capsid discovery company focused on drugging neural circuits. Saniaโs mission is to develop gene therapies that are precisely... ... Find ...See details»
Sania Therapeutics - EU-Startups
Sania's mission is to develop gene therapies that are specifically targeted to neural circuits to normalise their function and improve the quality of life of people with neurological diseases.See details»
Sania Therapeutics presents latest from AAV gene therapy โฆ
Apr 23, 2024 For more information visit www.saniarx.com. Sania Therapeutics Andrew Murray +4407354836683 [email protected]. ICR Consilium Mary-Jane Elliott Lucy Featherstone +44 โฆSee details»
Sania Therapeutics - Overview, News & Competitors - ZoomInfo
Www.saniarx.com. Revenue <$5M. Industry. Business Services General Business Services Sania Therapeutics's Social Media. Is this data correct? Popular Searches Sania Therapeutics SIC โฆSee details»
Science - Sania Therapeutics
We have proprietary technologies that harness our "human-first" approach to engineering cell-type specific gene delivery vectors. Our platforms effectively recreate functional human neural โฆSee details»
Careers - Sania Therapeutics
Want to work on something exciting, meaningful and transformative? Sania's therapeutics have remarkable potential to save lives and transform livelihoods.See details»
Sania Therapeutics launches to advance novel medicines for neural ...
May 17, 2023 Sania Therapeutics launches to advance novel medicines for neural circuit dysfunction Sania emerges from stealth mode and presents key proof-of-concept data at โฆSee details»
Sania Therapeutics launches to advance novel medicines for
May 17, 2023 Sania Therapeutics Andrew Murray +4407354836683 [email protected]: Consilium Strategic Communications Mary-Jane Elliott Lucy Featherstone +44 (0)20 3709 5700See details»
Sania Therapeutics Launches to Advance Novel Medicines for โฆ
DRUG DEVELOPMENT & DELIVERY 170 Changebridge Road Suite C5-4 Montville, NJ 07045 Tel: (973) 299-1200 Fax: (973) 299-7937See details»
News - Sania Therapeutics
May 17, 2023 Sania Therapeutics launches to advance novel medicines for neural circuit dysfunction. Read more about ho w Sania emerged out of stealth to launch our core โฆSee details»